Have you or your loved ones been diagnosed with dermatomyositis?

You may be eligible to participate in a dermatomyositis clinical trial.

Have you or your loved ones been diagnosed with dermatomyositis? You may be eligible to participate in a dermatomyositis clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Dermatomyositis Clinical Trial
NCT04044690 | Phase 3 | Interventional
CSL Behring
Sponsored by
CSL Behring

Have you or your loved ones been diagnosed with dermatomyositis?

You may be eligible to participate in a dermatomyositis clinical trial.

Have you or your loved ones been diagnosed with dermatomyositis? You may be eligible to participate in a dermatomyositis clinical trial.

Recruiting

Male & Female

18 Years +

This study is looking to recruit 126 Participants

This is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of IgPro20 (subcutaneous Ig) treatment in adult subjects with dermatomyositis (DM). The primary objective of this study is to assess the efficacy of IgPro20 subcutaneous (SC) doses in comparison to placebo in adult subjects with DM, as measured by responder status based on Total Improvement Score (TIS) assessments.

Available locations
CSLB Research Site

CSLB Research Site

Recruiting Bunkyō-Ku, JPN 113-8603

CSLB Research Site

CSLB Research Site

Recruiting Cherkasy, UKR 18009

CSLB Research Site

CSLB Research Site

Recruiting Essen, DEU 45147

CSLB Research Site

CSLB Research Site

Recruiting Kanagawa, JPN 216-8511

CSLB Research Site

CSLB Research Site

Recruiting Khmelnytskyi, UKR 29000

CSLB Research Site

CSLB Research Site

Recruiting Kiev, UKR 04070

CSLB Research Site

CSLB Research Site

Recruiting Maebashi, JPN 371-6511

CSLB Research Site

CSLB Research Site

Recruiting Moscow, 105554

CSLB Research Site

CSLB Research Site

Recruiting Nizhny Novgorod, 603005

Interested in learning more?
CSL Behring
Sponsored by CSL Behring

To get started, please choose a location